Patent ID: 9295698
Filing Date: 2016-03-29
CPC Classification: A61K,A61P

Claim Text:
1. A dietary supplement composition comprising a therapeutically effective amount to treat in an individual a disorder of the eye selected from the group consisting of dry eye syndrome and macular degeneration, and comprising krill oil that is about 58 percent to about 99.5 percent by weight of the total composition, and containing phospholipid bound and triglyceride bound EPA and DHA in which the krill oil contains at least 30% total phospholipids, S, S′-astaxanthin derived from Haematococcus pluvialis , lutein, and trans-zeaxanthin, wherein the 3S, 3′S-astaxanthin derived from Haematococcus pluvialis (Hp) is 0.1 to 16 percent by weight of the krill oil, the lutein is 0.4 to 30 percent by weight of the krill oil, and the trans-zeaxanthin is 0.04 to 24 percent by weight of the krill oil in an oral dosage form and in a single dosage capsule, wherein the composition includes 50 to 500 mg of krill oil per daily dose in the oral single dosage capsule.